ACGGX
Price
$30.85
Change
+$0.38 (+1.25%)
Updated
Jun 2 closing price
Net Assets
1.69B
FGDCX
Price
$52.46
Change
+$0.62 (+1.20%)
Updated
Jun 2 closing price
Net Assets
4.23B
Interact to see
Advertisement

ACGGX vs FGDCX

Header iconACGGX vs FGDCX Comparison
Open Charts ACGGX vs FGDCXBanner chart's image
ACGGX vs FGDCX Comparison Chart in %
View a ticker or compare two or three
VS
ACGGX vs. FGDCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACGGX is a Buy and FGDCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FGDCX has more cash in the bank: 4.23B vs. ACGGX (1.69B). FGDCX pays higher dividends than ACGGX: FGDCX (4.68) vs ACGGX (0.64). ACGGX was incepted earlier than FGDCX: ACGGX (28 years) vs FGDCX (19 years). FGDCX (1.69) is less costly to investors than ACGGX (0.91). FGDCX is a more actively managed with annual turnover of: 60.00 vs. ACGGX (20.00). FGDCX has a lower initial minimum investment than ACGGX: FGDCX (0) vs ACGGX (2500). ACGGX annual gain was more profitable for investors over the last year : 62.55 vs. FGDCX (57.95). ACGGX return over 5 years is better than : 137.43 vs. FGDCX (101.94).
ACGGXFGDCXACGGX / FGDCX
Total Expense Ratio0.911.6954%
Annual Report Gross Expense Ratio0.911.6954%
Fund Existence28 years19 years-
Gain YTD0.7943.68722%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.69B4.23B40%
Annual Yield % from dividends0.644.6814%
Returns for 1 year62.5557.95108%
Returns for 3 years194.19166.43117%
Returns for 5 years137.43101.94135%
Returns for 10 years254.16179.26142%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHE88.143.11
+3.66%
Benchmark Electronics
MB7.000.08
+1.16%
Masterbeef Group
ROIV28.27-0.82
-2.82%
Roivant Sciences Ltd
BBOT8.24-0.31
-3.63%
BridgeBio Oncology Therapeutics Inc
MGRX0.38-0.04
-8.85%
Mangoceuticals Inc